Polyneuropathy - Hearing Loss - Ataxia - Retinitis Pigmentosa - Cataract
Neurology
Prevalence
25.0 / 100K
Incidence
1.5 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Polyneuropathy - Hearing Loss - Ataxia - Retinitis Pigmentosa - Cataract?
There are 1 clinical trial targeting Polyneuropathy - Hearing Loss - Ataxia - Retinitis Pigmentosa - Cataract tracked by BioSniper.
What is the prevalence of Polyneuropathy - Hearing Loss - Ataxia - Retinitis Pigmentosa - Cataract?
The estimated prevalence of Polyneuropathy - Hearing Loss - Ataxia - Retinitis Pigmentosa - Cataract is approximately 25.0 per 100,000 population.
Deep-dive into Polyneuropathy - Hearing Loss - Ataxia - Retinitis Pigmentosa - Cataract
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis